HomeInsightsResults

Dr Lal Pathlabs Ltd Quarterly Result

Dr Lal Pathlabs Ltd Quarterly Result

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

1.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Dr Lal Pathlabs Ltd

NSE: LALPATHLAB

Net Profit

₹ 130.8

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Dr Lal Pathlabs Ltd for the Sep '24 is ₹ 682.1 crore as compare to the Jun '24 revenue of ₹ 622.5 crore. This represent the growth of 9.574293%.
  • The ebitda of Dr Lal Pathlabs Ltd for the Sep '24 is ₹ 224.4 crore as compare to the Jun '24 ebitda of ₹ 190.6 crore. This represent the growth of 17.733467%.
  • The net profit of Dr Lal Pathlabs Ltd for the Sep '24 is ₹ 130.8 crore as compare to the Jun '24 net profit of ₹ 107.8 crore. This represent the growth of 21.335806%.

Results Analysis

Market Price of Dr Lal Pathlabs Ltd

1M

1Y

3Y

5Y

Monitoring Dr Lal Pathlabs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20243028.25
19 Nov 20243040.9
18 Nov 20242968.2
14 Nov 20242953.7
13 Nov 20242964.25
12 Nov 20243027.6
11 Nov 20243011.1
08 Nov 20243058.8
07 Nov 20243071.1
06 Nov 20243100.2

Historical Revenue of Dr Lal Pathlabs Ltd

No data available

* All values are in crore

Historical EBITDA of Dr Lal Pathlabs Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Lal Pathlabs Ltd

No data available

* All values are in crore

Dr Lal Pathlabs Ltd News Hub

News

Dr. Lal PathLabs allots Equity shares

Dr. Lal PathLabs approved allotment of 5,000 Equity Shares under the ESOP 2010 Plan of the...

Read more

30 Oct 202411:47

News

Board of Dr. Lal PathLabs recommends Second Interim dividend

Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held ...

Read more

23 Oct 202416:18

News

Dr. Lal PathLabs to declare Quarterly Result

Dr. Lal PathLabs will hold a meeting of the Board of Directors of the Company on 23 Octobe...

Read more

17 Oct 202415:53

News

Dr Lal Pathlabs allots 93,900 equity shares under ESOP

Dr Lal Pathlabs has allotted 93,900 equity shares under Dr. Lal PathLabs Employee Stock Op...

Read more

13 Aug 202409:10

News

Board of Dr. Lal PathLabs recommends interim dividend

Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held ...

Read more

07 Aug 202416:35

News

Dr Lal PathLabs gains after Q1 PAT rises 29% YoY to Rs 108 cr

Revenue from operations increased 11.26% YoY to Rs 601.9 crore during the quarter. Profit ...

Read more

07 Aug 202415:36

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2023

PPT

July 2021

Transcript

June 2021

TranscriptPPT

May 2021

PPT

Jan 2021

PPT

Dec 2020

Transcript

July 2020

PPT

June 2020

TranscriptPPT

FAQ's For Dr Lal Pathlabs Ltd Quarterly Result

What is the EPS of Dr Lal Pathlabs Ltd stock?

The Earnings Per Share (EPS) of Dr Lal Pathlabs Ltd is 48.03. An EPS is the amount of net income attributed to each share of a common stock.

How is Dr Lal Pathlabs Ltd EPS calculated?

The EPS of Dr Lal Pathlabs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Dr Lal Pathlabs Ltd report its EPS?

Dr Lal Pathlabs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Dr Lal Pathlabs Ltd EPS?

Factors that influence the EPS of Dr Lal Pathlabs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Dr Lal Pathlabs Ltd EPS growth indicate future performance?

Yes, consistent growth in Dr Lal Pathlabs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*